Dong M - Search Results

1

[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].

Qin Y, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang JL, Yang S, Zhang CG, Dong M, Zhou LQ, Wang JW, Feng FY, Sun Y. Qin Y, et al. Among authors: dong m. Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):469-73. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950562 Chinese.

2

[Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line].

Dong M, Feng FY, Lin C, Zhang XY, Fu M, Liang X, Zha YY, Lu HY, Wu M. Dong M, et al. Zhonghua Yi Xue Za Zhi. 2004 Feb 17;84(4):323-8. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15059518 Chinese.

3

[Development and characterization of a gemcitabine-resistant variant of human lung adenocarcinoma cell line A549].

Dong M, Lin C, Feng FY, Zhang XY, Fu M, Liang X, Lu HY, Zha YY, Wu M. Dong M, et al. Ai Zheng. 2004 Jun;23(6):667-71. Ai Zheng. 2004. PMID: 15191667 Chinese.

4

[Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].

Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY. Zhou SY, et al. Among authors: dong m. Ai Zheng. 2005 Apr;24(4):465-9. Ai Zheng. 2005. PMID: 15820071 Chinese.

5

Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.

Shi Y, He X, Yang S, Ai B, Zhang C, Huang D, Dong M, Liu P, Zhou S, Han X. Shi Y, et al. Among authors: dong m. Chemotherapy. 2007;53(1):44-50. doi: 10.1159/000098418. Epub 2007 Jan 3. Chemotherapy. 2007. PMID: 17202811 Clinical Trial.

6

[Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases].

Yu YX, Shi YK, He XH, Zhou LQ, Zhou SY, Dong M, Feng FY, Sun Y. Yu YX, et al. Among authors: dong m. Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2714-6. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18167252 Chinese.

7

[Progress in treatment of metastatic tumors in the bone by bisphosphonate].

Dong M, Chen XP, Feng FY. Dong M, et al. Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):801-3. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396633 Review. Chinese. No abstract available.

8

Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients.

Li B, Shi YK, He XH, Zou SM, Zhou SY, Dong M, Yang JL, Liu P, Xue LY. Li B, et al. Among authors: dong m. Int J Hematol. 2008 May;87(4):375-381. doi: 10.1007/s12185-008-0068-5. Int J Hematol. 2008. PMID: 18409078

9

[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].

Dong M, Feng FY, Zhang Y, Xie GR, Wang YJ, Liu JW, Song ST, Zhou QH, Ren J, Jiao SC, Li J, Wang XW, Chen Q, Wang ZH, Xu N, Feng JF. Dong M, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):215-20. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756940 Clinical Trial. Chinese.

10

[Efficacy of modified Hyper-CVAD regimen on non-Hodgkin's lymphoma and safety evaluation].

Shi W, Shi YK, He XH, Yang JL, Zhang CG, Zhou SY, Dong M, Liu P, Qin Y, Yang S, Gui L, Lv Z. Shi W, et al. Among authors: dong m. Ai Zheng. 2009 Oct;28(10):1083-7. doi: 10.5732/cjc.009.10044. Ai Zheng. 2009. PMID: 19799818 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,515 results

Search Page

Filters